Why I volunteered for a Covid-19 vaccine trial
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Tuesday
February 07, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
TUESDAY, FEBRUARY 07, 2023
Why I volunteered for a Covid-19 vaccine trial

World+Biz

Reuters
12 November, 2020, 07:15 pm
Last modified: 12 November, 2020, 07:23 pm

Related News

  • UNFPA and BRAC host knowledge dissemination event on Covid-19
  • The supply chain crisis opens door to resilience
  • Hong Kong will give away half a million plane tickets. Here’s who can get them first
  • US to end Covid-19 emergency declarations on 11 May
  • Covid remains a public health emergency, says WHO

Why I volunteered for a Covid-19 vaccine trial

It all began in July when the British government announced it was seeking lots of volunteers for large-scale clinical trials of new vaccines and only a month before, a good friend of mine here had died of Covid-19 after spending weeks on a ventilator. Curious, I completed an online form, figuring I wasn’t committing myself to anything

Reuters
12 November, 2020, 07:15 pm
Last modified: 12 November, 2020, 07:23 pm
Reuters journalist Steve Stecklow participates in a clinical trial of the experimental Novavax Covid-19 vaccine at the NIHR/Wellcome King's Clinical Research Facility in London, Britain. Photo: Reuters/Steve Stecklow
Reuters journalist Steve Stecklow participates in a clinical trial of the experimental Novavax Covid-19 vaccine at the NIHR/Wellcome King's Clinical Research Facility in London, Britain. Photo: Reuters/Steve Stecklow

So why did I volunteer to be injected with an experimental vaccine for Covid-19? That's what some of my friends wanted to know when I told them what I was doing.

"Who knows about the long term," texted a former college roommate. "Seems like a gamble."

It all began in July when the British government announced it was seeking lots of volunteers for large-scale clinical trials of new vaccines. Only a month before, a good friend of mine here had died of Covid-19 after spending weeks on a ventilator.

Curious, I completed an online form, figuring I wasn't committing myself to anything.

In late September, an email informed me that I was among more than 250,000 "pioneers in the fight against Covid-19" who had enlisted in the cause. On Oct. 1, I was invited to apply for a trial of a vaccine made by an American biotech company called Novavax Inc. It was seeking at the time up to 10,000 volunteers in the United Kingdom for a late-stage trial to determine the vaccine's safety and effectiveness.

"If you are aged 18-84 and in good health, you could be eligible to participate," the email stated. "The study involves six visits over a period of around 13 months. Reasonable travel expenses will be reimbursed."

Now, it was time to decide. I began researching the Novavax vaccine, which has received less attention than several others. On Monday, Pfizer Inc announced its Covid-19 vaccine candidate appeared to be more than 90% effective. In September, late-stage trials of a vaccine developed by the University of Oxford and AstraZeneca Plc were halted after a report of a serious neurological illness in a volunteer, although the trials later were permitted to resume.

To me, the Novavax vaccine seemed less risky. Although the Maryland-based company has never received approval for a vaccine, it's employing the same technology to create its Covid-19 candidate that it used with a promising flu shot. I've gotten inoculated against the flu every year for decades and never once had an adverse reaction.

The published results of the first phase of testing the Novavax vaccine also showed no serious side effects among more than 100 participants who were injected with it. The worst-case was someone who had a mild fever for a day.

I decided to go for it. I figured if life is ever going to return to normal, the world is going to need vaccines and volunteers to see if they work. On a selfish level, I liked the idea of getting inoculated as soon as possible, given how monotonous – and sometimes scary – my daily routine had become. I've become so risk-averse that my wife has called me her "jailer."

Another attraction: If I were to catch the virus, the researchers would carefully monitor me. In the UK, where there has been a surge in new Covid-19 cases to more than 20,000 a day, infected people essentially are on their own unless they require emergency care.

Of course, there was a 50-50 chance I would be injected with a placebo – a saline solution – that wouldn't protect me against anything. In testing vaccines, placebos are used as a control to see whether the real thing is more effective at fending off the virus.

And so, after an online and over-the-phone screening to determine if I had any medical conditions that disqualified me from the study, I was given an appointment for the first of two injections.

I showed up one recent morning at the clinical research facility at King's College Hospital in south London – a small, drab building that is part of a sprawling medical complex. To my surprise, the receptionist asked me to take off my "Churchill Pro" bike mask – which costs $33 and uses "British Military Filtration Technology" to block "almost 100%" of viruses – and replace it with a cheap, disposable one. I later learned this was because my super-duper mask potentially could be contaminated.

Several other volunteers were already in a large room getting set up. I met privately with a doctor who asked if I had any questions. I had a few: "What if the Novavax vaccine proved so successful that the trial was stopped? Would I be told whether I received the placebo and if so, be given the real vaccine?" The doctor told me that if I had gotten the placebo, I would have to wait a year since the researchers would want to keep monitoring every trial participant. Not what I wanted to hear.

"What if another vaccine is approved first and I was given the placebo? Would I be allowed to take that?" The doctor suggested that was possible.

After I signed a consent form to participate in the trial, she gave me a brief physical exam. Back in the large room, a nurse gave me a Covid-19 test, sticking a long swab up my throat and then through a nostril. Then he prepared to draw my blood. I warned him my veins were thin and often proved problematic. He proceeded to fail twice before calling over a colleague who had better luck.

The injection itself was uneventful. But when the nurse checked my blood pressure afterwards, it had spiked. He asked me to wait a few minutes and basically calm down. I thought about the meditation exercises I had always scoffed at but had recently tried to reduce pandemic-induced anxiety – breathe in, breathe out. It worked.

So far, I've experienced no side effects and am awaiting a second injection once three weeks have passed. Curious about my experience, I spoke to James Galloway, a senior clinical lecturer at King's College who is the doctor responsible for my trial.

He told me that no decisions have been made on what to do with volunteers who received the placebo if Novavax is shown to be effective or another vaccine is approved first. He later added, "If we get another vaccine that works, we'd want people to get that vaccine if they've had the placebo."

"We don't want anyone to suffer from participating in the study," he said.

A spokeswoman for Novavax later told me volunteers would discuss their options with the clinicians overseeing the trial sites.

Galloway said there's a theoretical risk if someone who got the Novavax vaccine is injected with a different one. "There's a chance you'd have a reaction."

He doesn't know how the UK Novavax trial is going so far because he doesn't have access to the data. But overall, he remains optimistic that effective vaccines against Covid-19 will arrive.

As it happens, the 42-year-old doctor contracted Covid-19 himself last spring. He said he had a fever for 10 days and was briefly hospitalized after developing a heart rhythm problem. "I wouldn't wish it on anyone," he said.

Coronavirus chronicle / Top News

COVID-19 / Covid-19 vaccine trials

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • The world's richest person is trying to head off a succession battle
    The world's richest person is trying to head off a succession battle
  • Illustration: TBS
    Foreign aid for national budget drops by $1 billion: Finance Minister
  • Photo: Reuters
    A tragedy that will also shake up the region's geopolitics

MOST VIEWED

  • The world's richest person is trying to head off a succession battle
    The world's richest person is trying to head off a succession battle
  • Rescuers search through rubble of collapsed buildings following an earthquake, in the rebel-held town of Sarmada, Syria February 6, 2023 in this still image obtained from a drone footage. WHITE HELMETS /Handout via REUTERS
    Syrians abroad fear political rifts will stop aid reaching quake victims
  • Photo: Reuters
    A tragedy that will also shake up the region's geopolitics
  • Photo: Collected
    Syria newborn pulled alive from quake rubble
  • Photo: Collected
    India plans to promote green tourism during G20 presidency
  • Sacks of refined sugar at a store in New Delhi, India.Photographer: T. Narayan/Bloomberg
    The world is about to have more sugar than it needs. So why have prices surged?

Related News

  • UNFPA and BRAC host knowledge dissemination event on Covid-19
  • The supply chain crisis opens door to resilience
  • Hong Kong will give away half a million plane tickets. Here’s who can get them first
  • US to end Covid-19 emergency declarations on 11 May
  • Covid remains a public health emergency, says WHO

Features

Photo: Reuters

A tragedy that will also shake up the region's geopolitics

1h | Panorama
Nimah designed by Compass Architects- Wooden tiles. Photo: Junaid Hasan Pranto

Trendy flooring designs to upgrade any space

12h | Habitat
Benefits of having high ceilings in your new home

Benefits of having high ceilings in your new home

11h | Habitat
Each Reverse Osmosi plant can produce approximately 8,000 litres of drinking water a day for around 250 families. Photo: Sadiqur Rahman

A drop in the ocean of persistent water crisis

13h | Panorama

More Videos from TBS

30% companies see double-digit growth even in hard times

30% companies see double-digit growth even in hard times

3h | TBS Insight
Challenging time waiting for RMG

Challenging time waiting for RMG

10h | TBS Round Table
"Full Moon Meditation" organized by Department of Theater and Performance Studies, University of Dhaka

"Full Moon Meditation" organized by Department of Theater and Performance Studies, University of Dhaka

10h | TBS Graduates
10 cricketers who have played over 400 T20 matches

10 cricketers who have played over 400 T20 matches

10h | TBS SPORTS

Most Read

1
Photo: Courtesy
Panorama

From 'Made in Bangladesh' to 'Designed in Bangladesh'

2
Leepu realised his love for cars from a young age and for the last 40 years, he has transformed, designed and customised hundreds of cars. Photo: Collected
Panorama

'I am not crazy about cars anymore': Nizamuddin Awlia Leepu

3
Master plan for futuristic Chattogram city in the making
Districts

Master plan for futuristic Chattogram city in the making

4
The International Monetary Fund (IMF) logo is seen outside the headquarters building in Washington, U.S., September 4, 2018. REUTERS/Yuri Gripas/File Photo
Economy

IMF approves $4.7 billion loan for Bangladesh, calls for ambitious reforms

5
Belal Ahmed new acting chairman of SIBL
Banking

Belal Ahmed new acting chairman of SIBL

6
Photo: Collected
Crime

Prime Distribution MD Mamun arrested in fraud case

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]